Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-18T14:53:44.726Z Has data issue: false hasContentIssue false

Mortality and employment after in-patient opiate detoxification

Published online by Cambridge University Press:  15 April 2020

A. Naderi-Heiden*
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
A. Gleiss
Affiliation:
Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Spitalgasse 23, 1090Vienna, Austria
C. Bäcker
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
D. Bieber
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
H. Nassan-Agha
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
S. Kasper
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
R. Frey
Affiliation:
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090Vienna, Austria
*
*Corresponding author. Tel.: +43 1 40 400 3568; fax: +43 1 40 400 3099. E-mail address: angela.naderi-heiden@meduniwien.ac.at (A. Naderi-Heiden).
Get access

Abstract

Aim

We considered that completed opiate detoxification resulted in increased life expectancy and earning capacity as compared to non-completed detoxification.

Methods

The cohort study sample included pure opioid or poly-substance addicts admitted for voluntary in-patient detoxification between 1997 and 2004. Of 404 patients, 58.7% completed the detoxification program and 41.3% did not. The Austrian Social Security Institution supplied data on survival and employment records for every single day in the individual observation period between discharge and December 2007. Statistical analyses included the calculation of standardized mortality rates for the follow-up period of up to 11 years.

Results

The standardized mortality ratios (SMRs) were between 13.5 and 17.9 during the first five years after discharge, thereafter they fell clearly with time. Mortality did not differ statistically significantly between completers and non-completers. The median employment rate was insignificantly higher in completers (12.0%) than in non-completers (5.5%). The odds for being employed were higher in pure opioid addicts than in poly-substance addicts (p = 0.003).

Conclusions

The assumption that completers of detoxification treatment have a better outcome than non-completers has not been confirmed. The decrease in mortality with time elapsed since detoxification is interesting. Pure opioid addicts had better employment prospects than poly-substance addicts.

Type
Original articles
Copyright
Copyright © Elsevier Masson SAS 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Backmund, M., Meyer, K., Henkel, C., Soyka, M., Reimer, J., Schutz, C.G.Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis. 2005; 24: 1729.CrossRefGoogle ScholarPubMed
Bargagli, A.M., Hickman, M., Davoli, M., Perucci, C.A., Schifano, P., Buster, M.et al.Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health. 2006; 16: 198202.CrossRefGoogle ScholarPubMed
Bargagli, A.M., Sperati, A., Davoli, M., Forastiere, F., Perucci, C.A.Mortality among problem drug users in Rome: an 18-year follow-up study, 1980–97. Addiction. 2001; 96: 14551463.CrossRefGoogle ScholarPubMed
Bauer, S.M., Loipl, R., Jagsch, R., Gruber, D., Risser, D., Thau, K.et al.Mortality in opioid–maintened patients after release from an addiction clinic. Eur Addict Res. 2008; 14: 8291.CrossRefGoogle ScholarPubMed
Becker, J.B., Hu, M.Sex differences in drug abuse. Front Neuroendocrinol. 2008; 29: 3647.CrossRefGoogle ScholarPubMed
Bird, S.M., Hutchinson, S.J.Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction. 2003; 98: 185190.CrossRefGoogle Scholar
Bjornaas, M.A., Bekken, A.S., Ojlert, A., Haldorsen, T., Jacobsen, D., Rostrup, M.et al.A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry. 2008; 8: 8.CrossRefGoogle ScholarPubMed
Breslow, N.E., Day, N.E.Statistical methods in cancer research volume II–the design and analysis of cohort studies. IARC Sci Publ. 1987 1406.Google ScholarPubMed
Callaghan, R.C., Cunningham, J.A.Gender differences in detoxification: predictors of completion and re-admission. J Subst Abuse Treat. 2002; 23: 399407.CrossRefGoogle ScholarPubMed
Darke, S., Kaye, S., Duflou, J.Systemic disease among cases of fatal opioid toxicity. Addiction. 2006; 101: 12991305.CrossRefGoogle ScholarPubMed
Davoli, M., Bargagli, A.M., Perucci, C.A., Schifano, P., Belleudi, V., Hickman, M.et al.Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007; 102: 19541959.CrossRefGoogle ScholarPubMed
Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., Burns, L.Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009; 105: 915.CrossRefGoogle ScholarPubMed
Ederer, F., Axtell, L.M., Cutler, S.J.The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961; 6: 101121.Google ScholarPubMed
Fridell, M., Hesse, M.Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users. Addict Behav. 2006; 31: 559565.CrossRefGoogle ScholarPubMed
Gesundheit Österreich GmbH Geschäftsbereich ÖBIG. Bericht zur Drogenstituation in Österreich 2009.Google Scholar
Ghodse, A.H., Reynolds, M., Baldacchino, A.M., Dunmore, E., Byrne, S., Oyefeso, A.et al.Treating an opiate-dependent inpatient population: a one-year follow-up study of treatment completers and noncompleters. Addict Behav. 2002; 27: 765778.CrossRefGoogle ScholarPubMed
Gossop, M., Stewart, D., Treacy, S., Marsden, J.A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002; 97: 3947.CrossRefGoogle ScholarPubMed
Hubbard, R.L., Craddock, S.G., Anderson, J.Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003; 25: 125134.CrossRefGoogle ScholarPubMed
Kornor, H., Waal, H.From opioid maintenance to abstinence: a literature review. Drug Alcohol Rev. 2005; 24: 267274.CrossRefGoogle ScholarPubMed
Madlung-Kratzer, E., Spitzer, B., Brosch, R., Dunkel, D., Haring, C.A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification. Addiction. 2009; 104: 15491557.CrossRefGoogle ScholarPubMed
Mattick, R.P., Breen, C., Kimber, J., Davoli, M.Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 3: 2009 CD002209.Google ScholarPubMed
Michel, L., Giorgi, R., Villes, V., Poizot-Martin, I., Dellamonica, P., Spire, B.et al.Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART). Drug Alcohol Depend. 2009; 99: 96104.CrossRefGoogle ScholarPubMed
Price, R.K., Risk, N.K., Murray, K.S., Virgo, K.S., Spitznagel, E.L.Twenty-five year mortality of US servicemen deployed in Vietnam: predictive utility of early drug use. Drug Alcohol Depend. 2001; 64: 309318.CrossRefGoogle ScholarPubMed
Reece, A.C.Favorable mortality profile of naltrexone implants for opiate addiction. J Addict Dis. 2010; 29: 3050.CrossRefGoogle ScholarPubMed
Risser, Hönigschnabl, S., Stichenwirth, M., Pfudl, S., Sebald, D., Kaff, A.et al.Mortality of opiate users in Vienna Austria. Drug and alcohol dependence. 2001; 64: 251256.CrossRefGoogle ScholarPubMed
Rosen, D., Smith, M.L., Reynolds, C.F.The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry. 2008; 16: 488497.CrossRefGoogle ScholarPubMed
Sees, K.L., Delucchi, K.L., Masson, C., Rosen, A., Clark, H.W., Robillard, H.et al.Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000; 283: 13031310.CrossRefGoogle ScholarPubMed
Statistik Austria. Demographisches Jahrbuch 2005 Vienna 2006.Google Scholar
Strang, J., McCambridge, J., Best, D., Beswick, T., Bearn, J., Rees, S.et al.Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003; 326: 959960.CrossRefGoogle ScholarPubMed
Tait, R.J., Ngo, H.T.T., Hulse, G.K.Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment. J Subst Abuse Treat. 2008; 35: 116124.CrossRefGoogle ScholarPubMed
Termorshuizen, F., Krol, A., Prins, M., van Ameijden, E.J.Long-term outcome of chronic drug use: the Amsterdam Cohort Study among drug users. Am J Epidemiol. 2005; 161: 271279.CrossRefGoogle ScholarPubMed
Van den Brink, W., Haasen, C.Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006; 51: 635646.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.